Prospective study of wide local excision and endocrine therapy WithOut RadioTHerapy (WORTH) for node-negative, estrogen receptor-positive early breast cancer with negative histologic margins (WORTH trial, Protocol 1): Three-year interim results

Prospective study of wide local excision and endocrine therapy without radiotherapy (WORTH) for node-negative, estrogen receptor-positive early breast cancer with negative histologic margins (WORTH trial, Protocol 1): Five-year interim results.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.568 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 568-568

Author(s):

R. Nishimura ◽

S. Ohsumi ◽

H. Inaji ◽

Y. Ohashi ◽

K. Suemasu ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prospective Study ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Local Excision ◽

Wide Local Excision ◽

Trial Protocol ◽

Node Negative ◽

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

10.1158/1538-7445.sabcs14-p6-08-10 ◽

2015 ◽

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision Making ◽

Clinical Decision ◽

Node Negative ◽

Estrogen Receptor Positive ◽

The Impact

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

10.1158/1538-7445.sabcs15-p2-08-01 ◽

2016 ◽

Author(s):

JA Sparano ◽

RJ Gray ◽

DF Makower ◽

KI Pritchard ◽

KS Albain ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Prospective Trial ◽

Low Risk ◽

Node Negative ◽

Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Clinical Drug Investigation ◽

10.1007/s40261-019-00842-0 ◽

2019 ◽

Vol 40 (1) ◽

pp. 25-32 ◽

Cited By ~ 2

Author(s):

Xiaoxia Wei ◽

Hong Sun ◽

Jie Zhuang ◽

Xiuhua Weng ◽

Bin Zheng ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Pharmacogenetic Testing ◽

Effectiveness Analysis ◽

P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer

The Breast ◽

10.1016/s0960-9776(11)70147-3 ◽

2011 ◽

Vol 20 ◽

pp. S46 ◽

Cited By ~ 3

Author(s):

J.-U. Blohmer ◽

T. Kühn ◽

M. Rezai ◽

S. Kümmel ◽

M. Warm ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Recurrence Score ◽

Oncotype Dx ◽

Impact Study ◽

Node Negative ◽

Estrogen Receptor Positive ◽

Oncotype Dx Recurrence Score

Abstract GS2-04: Improvements in long-term outcome for women with estrogen receptor positive (ER+) early stage breast cancer treated with 5 years of endocrine therapy: Analyses of 82,598 women in the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) database

10.1158/1538-7445.sabcs19-gs2-04 ◽

2020 ◽

Author(s):

Hongchao Pan ◽

Jeremy Braybrooke ◽

Richard Gray ◽

Richard Peto ◽

Rosie Bradley ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Early Stage ◽

Collaborative Group ◽

Term Outcome ◽

Long Term Outcome ◽

Erratum to “Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor–positive, node‐negative breast cancer—A National Cancer Database analysis”

Cancer ◽

10.1002/cncr.33816 ◽

2021 ◽

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Older Patients ◽

Adjuvant Endocrine Therapy ◽

National Cancer Database ◽

Database Analysis ◽

Node Negative ◽

Prospective Study of the Effect of the 21-Gene Assay on Adjuvant Clinical Decision-Making in Japanese Women With Estrogen Receptor-Positive, Node-Negative, and Node-Positive Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.10.017 ◽

2014 ◽

Vol 14 (3) ◽

pp. 191-197 ◽

Cited By ~ 28

Author(s):

Hideko Yamauchi ◽

Chizuko Nakagawa ◽

Hiroyuki Takei ◽

Calvin Chao ◽

Carl Yoshizawa ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision Making ◽

Clinical Decision ◽

Node Negative ◽

Gene Assay ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

5BA Prospective trial of endocrine therapy alone in patients with estrogen-receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

European Journal of Cancer ◽

10.1016/s0959-8049(16)31935-9 ◽

2015 ◽

Vol 51 ◽

pp. S714 ◽

Author(s):

J. Sparano ◽

R. Gray ◽

J.A. Zujewski ◽

D. Makower ◽

K. Pritchard ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Prospective Trial ◽

Low Risk ◽

Node Negative ◽

Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor‐positive, node‐negative breast cancer—a National Cancer Database analysis

Cancer ◽

10.1002/cncr.33489 ◽

2021 ◽

Author(s):

Nina Tamirisa ◽

Heather Lin ◽

Yu Shen ◽

Simona F. Shaitelman ◽

Meghan S. Karuturi ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Older Patients ◽

Adjuvant Endocrine Therapy ◽

National Cancer Database ◽

Database Analysis ◽

Node Negative ◽